Search

Author/Creator Rivera, Raquel

1. A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg. Issue 4 (29th June 2020)

Authors:
Llamas‐Velasco, Mar; Baniandrés, Ofelia; Rivera, Raquel; Reymundo Jimenez, Ana; Hospital, Mercedes; García Zamora, Elena; González‐Cantero, Álvaro; Andrés Lencina, Juan‐José; Daudén, Esteban; de la Cueva, Pablo
Journal:
Dermatologic therapy
Issue:
Volume 33:Issue 4(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. (3rd May 2016)

Authors:
García-Doval, Ignacio; Pérez-Zafrilla, Beatriz; Ferrandiz, Carlos; Carretero, Gregorio; Daudén, Esteban; de la Cueva, Pablo; Gómez-García, Francisco J; Herrera-Ceballos, Enrique; Belinchón-Romero, Isabel; Sánchez-Carazo, Jose Luis; López-Estebaranz, Jose-Luis; Alsina, Merce; Ferrán, Marta; Torrad...
Journal:
Journal of dermatological treatment
Issue:
Volume 27:Number 3(2016:Jun.)
Page Start:
203
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effectiveness and safety of guselkumab for the treatment of psoriasis in real‐world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group. Issue 2 (17th January 2022)

Authors:
del Alcázar, Elena; López‐Ferrer, Anna; Martínez‐Doménech, Álvaro; Ruiz‐Villaverde, Ricardo; Llamas‐Velasco, Mª. del Mar; Rocamora, Vicenç; Julià, Marc; Notario, Jaime; Fernández‐Freire, Lourdes Rodríguez; Sahuquillo‐Torralba, Antonio; Vidal, David; Rivera, Raquel; Carretero, Gregorio; Mateu, Alm...
Journal:
Dermatologic therapy
Issue:
Volume 35:Issue 2(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Fast and sustained improvement of patient‐reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting. Issue 8 (29th June 2022)

Authors:
Chicharro, Pablo; Llamas‐Velasco, Mar; Armesto, Susana; Herrera‐Acosta, Enrique; Vidal, David; Vilarrasa, Eva; Rivera, Raquel; De la Cueva, Pablo; Martorell‐Calatayud, Antonio; Ballescà, Ferrán; Belinchón, Isabel; Carretero, Gregorio; Rodríguez, Lourdes; Romero‐Maté, Alberto; Pujol‐Montcusí, Jose...
Journal:
Dermatologic therapy
Issue:
Volume 35:Issue 8(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study. (4th July 2019)

Authors:
Montes-Torres, Andrea; Aparicio, Gloria; Rivera, Raquel; Vilarrasa, Eva; Marcellán, María; Notario, Jaume; Soria, Caridad; Belinchón, Isabel; de la Cueva, Pablo; Ferrán, Marta; Carrascosa, Jose Manuel; Gómez, Francisco J.; Salgado, Laura; Velasco, Manuel; Descalzo, Miguel Ángel; García-Doval, Ign...
Journal:
Journal of dermatological treatment
Issue:
Volume 30:Number 5(2019)
Page Start:
461
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts. (1st March 2017)

Authors:
García‐Doval, I.; Hernández, M.V.; Vanaclocha, F.; Sellas, A.; de la Cueva, P.; Montero, D.; Rodríguez, Basilio; Barceló, Mireia; Farietta, Sandra; Montoro, María; González, Ainhoa; Herráez, Elena; Ruíz‐Montesino, Mª Dolores; Vargas, Carmen; Pérez‐Pampín, Eva; Ortiz, Ana Mª; Tomero, Eva; Sifuente...
Journal:
British journal of dermatology
Issue:
Volume 176:Number 3(2017)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study. Issue 6 (3rd September 2020)

Authors:
Rivera, Raquel; Velasco, Manuel; Vidal, David; Carrascosa, J. Manuel; Daudén, Esteban; Vilarrasa, E; Notario, Jaime; Ruíz‐Villaverde, Ricardo; Yanguas, Ignacio; García‐Latasa, Francisco Javier; Ferrán, Marta; Lázaro‐Simó, Anna; de la Cueva, Pablo; Salgado‐Boquete, Laura; Belinchón, Isabel
Journal:
Dermatologic therapy
Issue:
Volume 33:Issue 6(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry. (19th May 2022)

Authors:
Munera-Campos, Mónica; Vilar-Alejo, Jaime; Rivera, Raquel; Carrascosa, Jose-Manuel; Daudén, Esteban; Herrera-Acosta, Enrique; Sahuquillo-Torralba, Antonio; Gómez-García, Francisco J.; Baniandrés-Rodríguez, Ofelia; de la Cueva, Pablo; López-Estebaranz, Jose-Luis; Belinchón, Isabel; Ferran, Marta; ...
Journal:
Journal of dermatological treatment
Issue:
Volume 33:Number 4(2022)
Page Start:
2110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study. (3rd April 2022)

Authors:
Rivera, Raquel; Vilarrasa, E.; Ribera, M.; Roe, E.; Kueder-Pajares, T.; Zayas, A. I.; Martínez-Molina, L.; Mataix Díaz, J.; Rodríguez-Nevado, I. M.; Usero-Bárcena, T.; de la Mano, D.; García-Donoso, C.; Olveira, A.; Guinea, G.; Martín-Vázquez, V.; Ferran, M.
Journal:
Journal of dermatological treatment
Issue:
Volume 33:Number 3(2022)
Page Start:
1329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice. (2nd November 2015)

Authors:
Carrascosa, Jose-Manuel; Garcia-Doval, Ignacio; Pérez-Zafrilla, Beatriz; Carretero, Gregorio; Vanaclocha, Francisco; Daudén, Esteban; De la Cueva-Dobao, Pablo; Belinchón, Isabel; Alsina, Merce; López-Estebaranz, Jose-Luis; Ferrán, Marta; Torrado, Rosa; Rivera, Raquel; Carazo, Cristina; Barboza, L...
Journal:
Journal of dermatological treatment
Issue:
Volume 26:Number 6(2015:Dec.)
Page Start:
502
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗